Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Conference News ESC 2016

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

Shelley Wood

August 29, 2016

News Daily News

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

L.A. McKeown

May 24, 2016

News Daily News

Hemodynamic Guidance of Hydration Cuts Contrast Nephropathy in Patients With Kidney Disease, Heart Failure

Todd Neale

December 09, 2015

News Conference News TCT 2015

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Nicole Lou

October 13, 2015

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Todd Neale

July 13, 2015

News Daily News

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

June 09, 2015

News Industry News

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

May 26, 2015

News Daily News

Silent A-fib After Acute MI Portends Poor Outcome

Yael L. Maxwell

May 01, 2015

News Daily News

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

Todd Neale

January 28, 2015

News Conference News Cell Therapy 2013

Small Heart Failure Studies Show Positive Trends for Cell Therapy

January 27, 2013

News Daily News

CABG Plus Stem Cells Equals Improved LV Function in MI Patients with Heart Failure

Jason Kahn

June 06, 2011

Advertisement

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

Hemodynamic Guidance of Hydration Cuts Contrast Nephropathy in Patients With Kidney Disease, Heart Failure

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

Silent A-fib After Acute MI Portends Poor Outcome

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

Small Heart Failure Studies Show Positive Trends for Cell Therapy

CABG Plus Stem Cells Equals Improved LV Function in MI Patients with Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content